NASDAQ:KNSY - Kensey Nash Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Kensey Nash Corporation is a medical device company primarily focused in the field of regenerative medicine, which is the application of devices, materials and other therapies to help repair damaged or diseased tissues. The Company has a range of products, which are sold through strategic partners in multiple large medical markets, including cardiology, orthopaedic, sports medicine, spinal and general surgery. It also has an ongoing development and manufacturing program for products in the endovascular market. During the fiscal year ended June 30, 2010 (fiscal 2010), the Company manufactured and sold over 4.5 million resorbable product units representing approximately 230 commercialized products, to strategic partners and customers. In January 2011, the Company acquired Nerites Corporation. In June 2012, Koninklijke DSM NV acquired the Company. Receive KNSY News and Ratings via Email Sign-up to receive the latest news and ratings for KNSY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:KNSY Previous Symbol CUSIPN/A CIK1002811 Webwww.kenseynash.com Phone+1-484-7132100Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Kensey Nash (NASDAQ:KNSY) Frequently Asked Questions What is Kensey Nash's stock symbol? Kensey Nash trades on the NASDAQ under the ticker symbol "KNSY." Has Kensey Nash been receiving favorable news coverage? News coverage about KNSY stock has trended negative this week, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Kensey Nash earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned headlines about the medical device company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. How do I buy shares of Kensey Nash? Shares of KNSY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Kensey Nash's official website? The official website for Kensey Nash is http://www.kenseynash.com/. How can I contact Kensey Nash? Kensey Nash's mailing address is 735 Pennsylvania Drive, EXTON, PA 19341, United States. The medical device company can be reached via phone at +1-484-7132100. MarketBeat Community Rating for Kensey Nash (NASDAQ KNSY)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 62 (Vote Outperform)Underperform Votes: 70 (Vote Underperform)Total Votes: 132MarketBeat's community ratings are surveys of what our community members think about Kensey Nash and other stocks. Vote "Outperform" if you believe KNSY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KNSY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/26/2019 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?